SINGAPORE Medical Group on Wednesday posted a net profit of S$3.5 million in the second quarter, up 3.5 per cent from the same period a year earlier.

SINGAPORE (Aug 7): Singapore Medical Group saw its earnings rise 3.5% to $3.5 million for the 2Q19 ended June, from $3.4 million a year ago. On a fully diluted basis, earnings per share dipped to 0.69 cent in 3Q19, from 0.73 cent in 3Q18. 2Q19 revenue grew 6.8% to $23.1 million, from $21.6 million ...

CATALIST-LISTED Singapore Medical Group (SMG) said on Tuesday that it has exercised its option to convert the convertible loan of US$689,360 granted to CityClinic Asia Investments (CCAI) into 177,670 shares of CCAI at the conversion price of US$3.88 per share.

SINGAPORE (Aug 5): In early 2017, I bought some units in CapitaLand Commercial Trust to ride the tightening supply of top-end office space in Singapore. Even though stocks were rising, there was a fair amount of nervousness in the market. But I figured I would still earn a decent yield from CCT ami...

SINGAPORE (June 7): RHB Research is upgrading Singapore Medical Group (SMG) to “buy” from “neutral” previously, with an unchanged target price of 48 cents. SMG’s share price has fallen by 15% from 44.5 cents to 38 cents, which is a 52-week low since 10 May. This may have been due to recen...

Submitted By:  Nathanielle Punay Case Study:  No The sector’s market cap ballooned thirteen-fold and stands at over $40b. The five best-performing healthcare ...

Singapore’s healthcare system has been held up as an example for other governments to follow. But residents are growing old, and tired of ever-increasing costs. SINGAPORE (Mar 18): It was turning into a long-drawn-out ordeal. For six weeks, Angeline Yong’s septuagenarian father had complained o...

SINGAPORE (Feb 21): RHB Research is maintaining Singapore Medical Group (SMG) at “buy” on news that shareholder CHA Healthcare Singapore (CHAS) is raising its stake in the group. On Wednesday, SMG announced that CHAS and five existing shareholders have entered into an agreement to purchase a to...

CATALIST-LISTED healthcare play Singapore Medical Group (SMG) on Wednesday announced that it is deepening its partnership with CHA Healthcare Singapore, as the latter increases its stake in SMG from 6.8 per cent to 24.1 per cent.

CHA Healthcare Singapore has entered into a share purchase agreement to invest S$50 million in Catalist-listed Singapore Medical Group (SMG), increasing its stake from 6.86 per cent to 24.13 per cent, SMG announced in a filing to the Singapore Exchange on Wednesday.